MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Ketoconazole

CAS No. : 65277-42-1

MCE 站：Ketoconazole

产品活性：Ketoconazole (R-41400) 是咪唑类抗真菌剂，是经典的CYP3A4抑制剂,也是 CYP24A1的抑制剂。

研究领域：Anti-infection  |  Metabolic Enzyme/Protease  |  GPCR/G Protein

作用靶点：Fungal  |  Cytochrome P450  |  Ras

In Vitro: Ketoconazole (R-41400), an imidazole anti-fungal agent, has often produced features of androgen deficiency including decreased libido, gynecomastia, impotence, oligospermia, and decreased testosterone levels, in men being treated for chronic mycotic infections. Ketoconazole (R-41400) also is a cytochrome P450 inhibitor. Ketoconazole (R-41400), on the antischistosomal potential of these quinolines against Schistosoma mansoni infection by evaluating parasitological, histopathological, and biochemical parameters. Mice were classified into 7 groups: uninfected untreated (I), infected untreated (II), infected treated orally with PZQ (1,000 mg/kg) (III), QN (400 mg/kg) (IV), KTZ (10 mg/kg)+QN as group IV (V), HF (400 mg/kg) (VI), and KTZ (as group V)+HF (as group VI) (VII). KTZ plus QN or HF produced more inhibition (P<0.05) in hepatic CYP450 (85.7% and 83.8%) and CYT b5 (75.5% and 73.5%) activities, respectively, than in groups treated with QN or HF alone. This was accompanied with more reduction in female (89.0% and 79.3%), total worms (81.4% and 70.3%), and eggs burden (hepatic; 83.8%, 66.0% and intestinal; 68%, 64.5%), respectively, and encountering the granulomatous reaction to parasite eggs trapped in the liver. CYP24A1 inhibitor enhances antiproliferative effects, increases systemic calcitriol exposure, and promotes the activation of caspase-independent apoptosis pathway. Ketoconazole is also a potent exosome biogenesis and/or secretion inhibitor.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  GPCR/G Protein Compound Library  |  Kinase Inhibitor Library  |  Metabolism/Protease Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Antioxidants Compound Library  |  Oxygen Sensing Compound Library  |  Antifungal Compound Library  |  Ferroptosis Compound Library  |  NMPA-Approved Drug Library  |  Orally Active Compound Library  |  Glutamine Metabolism Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Exosomes Compound Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Anti-Blood Cancer Compound Library  |  Rapamycin  |  Ferrostatin-1  |  Cycloheximide  |  Staurosporine  |  Resveratrol  |  Tunicamycin  |  Hygromycin B  |  Oligomycin A  |  BI-2852  |  Camptothecin  |  Amphotericin B  |  Verapamil hydrochloride  |  Apigenin  |  Nystatin  |  NSC 23766 trihydrochloride  |  Calcimycin  |  Fenofibrate  |  Filipin complex  |  Mycophenolic acid  |  Idarubicin hydrochloride  |  Fluconazole  |  1-Aminobenzotriazole  |  ML141  |  Itraconazole  |  Rhosin hydrochloride  |  Abiraterone  |  Caspofungin Acetate  |  EHT 1864  |  CASIN

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。